期刊文献+

一氧化氮和血管紧张素Ⅱ在压力超负荷心肌肥大中的作用 被引量:1

THE ROLE OF NO AND ANG Ⅱ IN MYOCARDIAL HYPERTROPHY CAUSED BY PRESSURE OVERLOAD
暂未订购
导出
摘要 目的:观察一氧化氮(NO)和血管紧张素Ⅱ(AngⅡ)在压力超负荷心肌肥大反应过程中的作用。方法:利用腹主动脉缩窄性高血压大鼠模型,测量平均动脉压(MAP)和左心室质量/体质量比值(LVW/BW)。结果:在SD乳鼠腹主动脉缩窄性高血压模型中,MAP和LVW/BW呈时间依赖性增高,从术后第1周开始MAP和LVW/BW均明显增高,至第8周达高峰;NO前体L-Arg和AngⅡ1型受体(AT1)拮坑剂芦沙坦(Los),明显阻断腹主动脉缩窄性高血压大鼠的MAP和LVW/BW的增高效应;用NOS抑制剂NG-硝基左旋精氨酸甲酯(L-NAME)同时处理假手术组(Sham)和腹主动脉缩窄性(COA)高血压组大鼠,MAP和LVW/BW均进一步增高。结论:AngⅡ参与诱发压力超负荷高血压和心肌肥大反应的发生;NO具有抑制压力超负荷引起的高血压和心肌肥大反应。 To investigate the effects of nitric oxide (NO) and angiotensin Ⅱ on myocardial hypertrophy caused by overloaded pressure. Method: The coarctation of the abdominal aorta (COA) hypertension model was established in Spragrue-Dawley rats. The mean arterial pressure (MAP) and the ratio of left ventricular weight to body weight (LVW/BW) were measured in each rat. Results: The MAP and LVW/BW were significantly increased at week 1,4,8, and 12 with tis peak at week 8 after COA, Both NO precursor, L-Arg and angiotensin Ⅱ type one receptor (AT1) antagonist losartan (Los) and significantly blocked the in crease in MAP and LVW/BW cause by COA. In contrast, MAP and LVW/BW were increased further after the rats received NOS antagonist L-NAME in both sham and COA groups. Conclusion: Ang Ⅱ participats in the development of hypertension and myocardial hypertrophy induced by COA while NO may have the opposite effect.
出处 《海南医学院学报》 CAS 2002年第1期1-4,12,共5页 Journal of Hainan Medical University
基金 海南省自然科学基金(NO.30018) 省卫生厅资助课题(NO 琼卫2000-78)
关键词 心肌肥大 高血压 血管紧张素Ⅱ 一氧化氮 压力超负荷 Cardiac muscle hypertrophy hypertension angiotensin Ⅱ nitric oxide
  • 相关文献

参考文献11

  • 1Zabalgoitia M. Left ventricular mass and function in primary hypertension. Am J Hypertens, 1996,9:55-59
  • 2Baker KM.,Cherin MI.,Wixon SK,et al. Renin angiotensin system involvement inpressure overloadardiaeypertrophy in the rats. Am J Physiol, 1990,259: 324-332
  • 3苑利伟,李元建.内源性一氧化氮合酶抑制物与心血管疾病[J].中国动脉硬化杂志,1998,6(3):264-266. 被引量:3
  • 4Matsuoka H.,Itoh S.,Kimoto M.,et al. Asymmetric dimethylarginine,an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension,1997,29: 242-247
  • 5Huang PL., Huang ZH., Mashimo H., et al.Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature, 1995,377: 239-242
  • 6Bartunek J., Weinberg EO., Tajima M., et al. Chronic NGnitro-L-arginine methylester-induced hypertension:novel molecular adaptation to systolic load in absence ofhypertrophy. Circulation, 2000,101: 423-429
  • 7Turner SW., Wen C., Li M., et al. L-arginineprevents corticotropin-induced increases in blood pressure in the rat. Hypertension, 1996,27:184-189
  • 8高连如,刘国仗,赵云涛,陈思聪,石湘芸,熊监然,杨晔,张继峰,田青,唐朝枢,汤健.内皮素和内皮衍化的松弛因子在高血压发病上的作用[J].中华高血压杂志,1994,12(4):225-228. 被引量:2
  • 9Ji H., Leung M., Zhang Y., et al. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor.Identification of amino acid residues that determine binding of the antihypertensive drug losartan. J Biol Chem, 1994,269:16533-16536
  • 10Pinto YM., Pinto-Sietsma SJ.,Philipp T., et al. Reduction in left ventricular messenger RNA for trarsforming growth factor beta (1) attenuates left ventricular fibrosis and mproves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat. Hypertension, 2000,36: 747-754

二级参考文献2

共引文献3

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部